ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2024

Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists.

Teresa Vezza et al.PubMed ↗Publisher ↗

No numbers read from the abstract.